Rady Children’s Institute for Genomic Medicine is a non-profit research organization embedded within Rady Children’s Hospital-San Diego.
We pioneered a medical revolution to end the diagnostic odyssey for neonatal and pediatric rare disease. Now we’re moving to end the therapeutic odyssey.
They deserve that rapid diagnosis the first time they are hospitalized in intensive care – thereby saving them and their families countless tests and heartache.
And we are striving to end the therapeutic odyssey for children with devastating rare diseases by pinpointing the root cause of previously unidentified conditions.
Our scientists and innovators work on translating our discoveries into therapies and tools to guide clinical decision-making for providers at the bedside.
Rady Children’s Institute for Genomic Medicine pioneered a medical revolution through our record-breaking rapid Whole Genome Sequencing™ test. Our research into the use of rWGS® in a clinical NICU setting continues to lay the groundwork for systemic changes in pediatric healthcare.
The Institute’s vision is bold – we want to change the world – but with our finite resources, we can’t achieve it alone. This is why, in addition to doing groundbreaking genomic research, we are forming partnerships with like-minded organizations across the globe. It’s the reason we collaborate with other research institutions and business partners. It’s why we spend a great deal of time on thought leadership – working to share our vision and activate to advance the field.
Find out how much we achieved in Fiscal Year 2023 in our 9th annual Performance Report.
Along with optimizing our genome sequencing platform and Rapid Precision Medicine delivery system, we are scaling and sharing our tools and expertise in rare disease with a growing network of children’s hospitals globally to make cutting edge healthcare widely available.
Training and mentoring a workforce in the clinical application of genomic medicine is vital. We offer an array of educational opportunities for new and experienced clinicians to develop their expertise in this evolving field.
We are committed to scaling implementation of Rapid Precision Medicine, increasing public and private coverage of RPM® and empowering families affected by rare disease to become effective advocates. We invite collaborations with organizations in research, healthcare, industry and patient advocacy who share our vision for forging the future of genomic medicine.
Our History
Research use of whole genome sequencing begins at RCIGM
First Rady Children’s Hospital baby sequenced under research protocol
RCIGM celebrates 100th patient genome sequenced
NIH/NHGRI award Institute/UCSD $3.58M in funding for joint study on genetic and environmental factors that may be linked to infant deaths
Rady Children’s Hospital pledges $45M to the work of the Institute
RCIGM’s partner network reaches 81 children’s hospitals in 27 states and 3 countries.
RCIGM announces BeginNGS, a novel health care delivery system designed to screen newborns for genetic diseases — and connect their doctors with effective treatment options.
$1.2M Conrad Prebys Foundation gift supports
research to study technology to increase clinical utility of rWGS
First clinical trial for BeginNGS started, screening for 411 disorders
RCIGM’s rWGS® network of partner children’s hospitals hits 100
Rady Children’s Institute for Genomic Medicine® marks its tenth anniversary
© 2025 Rady Children's Institute for Genomic Medicine.
